Home/Filings/4/0001127602-23-002187
4//SEC Filing

Llorens Josep 4

Accession 0001127602-23-002187

CIK 0000313143other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 4:28 PM ET

Size

8.3 KB

Accession

0001127602-23-002187

Insider Transaction Report

Form 4
Period: 2023-01-23
Llorens Josep
SVP, Global Manufacturing
Transactions
  • Sale

    Common Stock

    2023-01-23$90.00/sh2,391$215,19017,234 total
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2023-01-232,3917,173 total
    Exercise: $56.57From: 2022-05-18Exp: 2028-05-18Common Stock (2,391 underlying)
  • Exercise/Conversion

    Common Stock

    2023-01-23$56.57/sh+2,391$135,25919,625 total
Footnotes (3)
  • [F1]Transaction pursuant to an existing 10b5-1 trading plan.
  • [F2]This number includes unvested restricted stock units previously reported.
  • [F3]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeother

Related Parties

1
  • filerCIK 0001750812

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:28 PM ET
Size
8.3 KB